Careers  |  Sign In  |  Register  |   Twitter

Latest in HIV/AIDS

BBC News reports that a study in Nature has found a possible vaccine against an HIV-like-virus. The study was conducted in a monkey model, where monkeys were injected with cytomegalovirus (CMV) as a vaccine and were then exposed to Simian Immunodeficiency Virus (SIV), which is similar to but “up to...
An article in The New York Times reports that a daily dose of isoniazid, a generic antibiotic, can “fend off a lethal bout of tuberculosis in people with H.I.V., according to a large new study.” The study found that “a daily isoniazid pill reduced deaths and active TB cases by 31 percent...
Bloomberg News reports that GlaxoSmithKline “won U.S. regulatory approval for a daily pill against the deadly HIV infection“ developed by ViiV Healthcare. The pill, called Tivicay, uses an “integrase strand transfer inhibitor that interferes with the enzymes necessary for HIV to...